期刊文献+

载脂蛋白A5基因原核表达及多克隆抗体的制备 被引量:1

原文传递
导出
摘要 ApoA5是人apoAI-CⅢ-AIV基因序列中1个血浆载脂蛋白基因家族新成员。构建ApoA5基因敲除及ApoA5转基因鼠模型研究证实,ApoA5可调节TG水平,是冠状动脉疾病一个独立负危险因子。研究证实,-1131T/C与高TG呈负相关;-1131T/C与2型糖尿病、心血管疾病高度相关。本研究采用重组ApoA5蛋白免疫新西兰大白兔,制备高效价兔抗人ApoA5多克隆抗体,建立分析临床标本的检测方法,为进一步研究ApoA5调节血脂的机制及其与心血管疾病的关系提供技术工具。
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2010年第2期170-172,共3页 Chinese Journal of Laboratory Medicine
基金 江苏省南京市科技发展重点项目资助课题(ZKM06055)
  • 相关文献

参考文献13

  • 1Van der Vliet HN, Sammels MG, Leegwater AC, et al. Apolipoprotein AV : a novel apolipoprotein associated with an early phase of liver regeneration. Biol Chem, 2001,276:44512-44520.
  • 2Pennacchio LA,-Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglyeerides in humans and mice revealed by comparative sequencing. Science, 2001,294 : 169-173.
  • 3Lai CQ, Demissie S, Cupples LA, et al. Infuence of the APOA5 locus on plasma triglyceride, lipoprotein in subclasses, and CVD risk in the Franlingham Heart Study. J Lipid Res, 2004,45:2096- 2105.
  • 4Sousa MO, Alia P, Pinto X, et al. Interaction between ApoA5 - 1131T > C and APOE polymorphisms and their association with severe hypertrigly-ceridemia. Clinica Chimica Acta, 2008,395 : 68-71.
  • 5Liu Y, Ordovas JM, Gao G, et al. Pharmacogenetic association of the apoA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the Genetics of Lipid-Lowering Drugs and Diet Network study. Pharmacogenet C, enomics, 2009,19 : 161-169.
  • 6Girona J, Guardiola M, Cabre A, et al. The apolipoprotein A5 gene -1131T > C polymorphism affects vitamin Eplasma concentrations in type 2 diabetic patients. Clin Chem Lab Med, 2008,46:453-457.
  • 7中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 8魏红霞,张葵,李雷,邱方,顾光煜,倪军.重组人载脂蛋白A5原核表达载体的构建及分析鉴定[J].临床检验杂志,2009,27(1):53-56. 被引量:3
  • 9魏红霞,张葵,李雷,倪军,邱方,顾光煜.血清载脂蛋白A5 ELISA法的建立及评价[J].临床检验杂志,2009,27(5):355-357. 被引量:10
  • 10Li GP, Wang JY, Yah SK, et al. Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese pooulation. Clin Genet, 2004,65:470-476.

二级参考文献186

共引文献5242

同被引文献11

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 2Taia ES,Ordovas JM.Clinical significance of apolipoprotein A5.Curr Opin Lipidol,2008,19:349-354.
  • 3Nowak M,Helleboid-Chapman A,Jakel H,et al.Glucose regulates the expression of the apolipoprotein A5 gene.J Mol Biol,2008,380:789-798.
  • 4Alborn WE,Prince MJ,Konrad RJ.Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes.Clinica Chimica Acta,2007,378:154-158.
  • 5Vliet HN,Sammels MG,Leegwater AC,et al.Apolipoprotein A-V:a novel apolipoprotcin associated with an early phase of liver regeneration.J Biol Chem,2001,276:44512-44520.
  • 6O'Brien PJ,Alborn WE,Sloan JH,et al.The novel apolipoprotein A5 is present in human serum,is associated with VLDL,HDL,and chylomicrons,and circulates at very low concentrations compared with other apolipoproteins.Clin Chem,2005,51:351-359.
  • 7Pennacchio LA,Olivier M,Hubacek JA,et al.An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.Science,2001,294:169-173.
  • 8Hyun YJ,Jang YS,Chae JS,et al.Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men.Atherosclerosis,2009,205:568-573.
  • 9Xie L,Jones RM,Thomas RG,et al.Measurement of the functional affinity constant of a monoclonal antibody for cell surface receptors using kinetic exclusion fluorescence immunoassay.J Immunol Methods,2005,304:1-14.
  • 10魏红霞,张葵,李雷,邱方,顾光煜,倪军.重组人载脂蛋白A5原核表达载体的构建及分析鉴定[J].临床检验杂志,2009,27(1):53-56. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部